These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38677716)
1. Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches. Torres-Maravilla E; Carvalho FA; Holowacz S; Delannoy J; Lenoir L; Jacouton E; Barbut F; Langella P; Bermúdez-Humarán LG; Waligora-Dupriet AJ Benef Microbes; 2024 Apr; 15(3):293-310. PubMed ID: 38677716 [TBL] [Abstract][Full Text] [Related]
2. In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity. Le Barz M; Daniel N; Varin TV; Naimi S; Demers-Mathieu V; Pilon G; Audy J; Laurin É; Roy D; Urdaci MC; St-Gelais D; Fliss I; Marette A FASEB J; 2019 Apr; 33(4):4921-4935. PubMed ID: 30596521 [TBL] [Abstract][Full Text] [Related]
3. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches. Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412 [TBL] [Abstract][Full Text] [Related]
4. Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice. Laval L; Martin R; Natividad JN; Chain F; Miquel S; Desclée de Maredsous C; Capronnier S; Sokol H; Verdu EF; van Hylckama Vlieg JE; Bermúdez-Humarán LG; Smokvina T; Langella P Gut Microbes; 2015; 6(1):1-9. PubMed ID: 25517879 [TBL] [Abstract][Full Text] [Related]
9. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells. Čitar M; Hacin B; Tompa G; Štempelj M; Rogelj I; Dolinšek J; Narat M; Matijašić BB Benef Microbes; 2015; 6(3):325-36. PubMed ID: 25391349 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect. Presti I; D'Orazio G; Labra M; La Ferla B; Mezzasalma V; Bizzaro G; Giardina S; Michelotti A; Tursi F; Vassallo M; Di Gennaro P Appl Microbiol Biotechnol; 2015 Jul; 99(13):5613-26. PubMed ID: 25744647 [TBL] [Abstract][Full Text] [Related]
11. Serpin-positive Bifidobacterium breve CNCM I-5644 improves intestinal permeability in two models of irritable bowel syndrome. Torres-Maravilla E; Holowacz S; Delannoy J; Lenoir L; Jacouton E; Gervason S; Meynier M; Boucard AS; Carvalho FA; Barbut F; Bermúdez-Humarán LG; Langella P; Waligora-Dupriet AJ Sci Rep; 2022 Nov; 12(1):19776. PubMed ID: 36396717 [TBL] [Abstract][Full Text] [Related]
12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240 [TBL] [Abstract][Full Text] [Related]
13. Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model. Hong KB; Seo H; Lee JS; Park Y BMC Complement Altern Med; 2019 Jul; 19(1):195. PubMed ID: 31366385 [TBL] [Abstract][Full Text] [Related]
14. Multispecies probiotic protects gut barrier function in experimental models. Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474 [TBL] [Abstract][Full Text] [Related]
15. Evidence from comparative genomic analyses indicating that Liu Y; Xiao W; Yu L; Tian F; Wang G; Lu W; Narbad A; Chen W; Zhai Q Food Funct; 2021 Feb; 12(3):1121-1134. PubMed ID: 33427835 [TBL] [Abstract][Full Text] [Related]
16. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Agostini S; Goubern M; Tondereau V; Salvador-Cartier C; Bezirard V; Lévèque M; Keränen H; Theodorou V; Bourdu-Naturel S; Goupil-Feuillerat N; Legrain-Raspaud S; Eutamene H Neurogastroenterol Motil; 2012 Apr; 24(4):376-e172. PubMed ID: 22272920 [TBL] [Abstract][Full Text] [Related]
18. Three Novel Candidate Probiotic Strains with Prophylactic Properties in a Murine Model of Cow's Milk Allergy. Neau E; Delannoy J; Marion C; Cottart CH; Labellie C; Holowacz S; Butel MJ; Kapel N; Waligora-Dupriet AJ Appl Environ Microbiol; 2016 Jan; 82(6):1722-1733. PubMed ID: 26729723 [TBL] [Abstract][Full Text] [Related]
19. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Roselli M; Finamore A; Britti MS; Mengheri E Br J Nutr; 2006 Jun; 95(6):1177-84. PubMed ID: 16768842 [TBL] [Abstract][Full Text] [Related]
20. Probiotic strains modulate cytokine production and the immune interplay between human peripheral blood mononucear cells and colon cancer cells. Djaldetti M; Bessler H FEMS Microbiol Lett; 2017 Feb; 364(3):. PubMed ID: 28104778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]